bat365官网登录入口

院长论坛

报告题目：Development of prohibitin ligands to treat cancers, cardiac and inflammatory disorders

报 告 人：Laurent Désaubry Professor

                    CNRS-Strasbourg University, France & Tianjin University of Science and Technology, China

时             间：2019 年3 月14 日（星期四）中午12：00-1：00

地          点：生理楼三层中厅

主 持 人：孔炜教授

报告人简介：

Dr Laurent Désaubry is a CNRS research director in the Laboratory of Cardio-Oncology at the University of Strasbourg in France (website: http://desaubry.u-strasbg.fr/) and adjunct professor at Tianjin University of Science and Technology (TUST) in China. In 1992, he received a Ph.D. degree in medicinal chemistry from Strasbourg University. Next, he worked as a postdoctoral fellow at SUNY at Stony Brook, USA. He made another post-doctoral internship in Prof. Pierre Chambon’s laboratory in France before to get a CNRS senior scientist position at the University of Strasbourg-CNRS. He was promoted CNRS research director (corresponds to full professor) in 2014, and became also adjunct professor at TUST in 2015.

欢迎师生参加！